Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casu...

What this episode covers

BloodCancerTalks: ASH 2025 Lymphoma RoundupGuest: Dr. Carla Casulo, Associate Professor, Wilmot Cancer Centre, University of RochesterAbstracts DiscussedFollicular LymphomaEPCORE-FL1 (Falchi) - Epcoritamab plus lenalidomide-rituximab (R2) in relapsed/refractory FLTheme: Bispecific antibody combinations in R/R FL; comparing to other approaches Diffuse Large B-Cell Lymphoma (DLBCL) - Elderly/Unfit PatientsMorningSun (Sharman) - Mosunetuzumab monotherapy in patients ≥80 years or chemo-ineligibleEPCOR-DLBCL-3 (Vitolo) - Epcoritamab monotherapy in elderly patientsR-Pola-Glo - Rituximab-polatuzumab-glofitamab combination in older/frail patientsTheme: Single-agent and combination bispecific strategies for elderly and frail DLBCL patients DLBCL - First-Line TreatmentSMART STOP (Westin) - Chemotherapy-free approach using lenalidomide, tafasitamab, rituximab, acalabrutinib (ULTRA regimen)FrontMIND - Tafasitamab-lenalidomide added to R-CHOPTheme: Chemotherapy-sparing and chemo-intensification strategies in newly diagnosed DLBCL DLBCL - Relapsed/RefractoryDALY 2-EU (Borchmann) - Dual CD19/CD20 CAR-T (zamto-cel) versus R-GemOx in transplant-ineligible patientsTheme: Expanding CAR-T eligibility; treatment selection in transplant-ineligible R/R DLBCL Hodgkin LymphomaSWOG 1826 - 3-year update: Nivolumab-AVD versus brentuximab-AVDHD21 - 5-year update: PET-adapted BrECADD versus BEACOPPTheme: Long-term outcomes and treatment selection in newly diagnosed Hodgkin lymphoma Burkitt LymphomaZUMA-25 (Van Dorp) - Brexucabtagene autoleucel (Brexu-cel) in relapsed/refractory BurkittTheme: CAR-T therapy for the challenging population of R/R Burkitt lymphoma Mantle Cell Lymphoma - First-Line TrAVeRse - Acalabrutinib, venetoclax, rituximabGLOVe - Glofitamab, lenalidomide, venetoclax (high-risk MCL)BOVen - Zanubrutinib, obinutuzumab, venetoclax (older patients)MAVO - Acalabrutinib, venetoclax, obinutuzumabWindow-3 - Acalabrutinib-rituximab followed by brexu-cel (high-risk MCL)Theme: Chemotherapy-free combinations in newly diagnosed mantle cell lymphoma

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

The Lee Olsen Show Lee Olsen CJF I want to help you improve all areas of your life by 3 types of podcasts!👉Blood, Sweat & Blessings-Interviews of normal people that have achieved BIG things!👉Series!!! For Love of the Horse- Brad Jackman DVM & Lee Olsen CJF, how to help your horse!👉Business Tips- Proven Life Changing Business Strategies with Lee Olsen Carnivores Don't Get Sunburn - Carnivore Diet Talks Carnivores Don't Get Sunburn - Carnivore Diet Talks Welcome to “Carnivores Don’t Get Sunburn,” where we have fun and explore the carnivore diet and its transformative power. Join us as we uncover real stories from individuals who have thrived on this diet, defying convention and embracing optimal health. Plus, stay tuned for our upcoming documentary featuring diverse carnivores overcoming health challenges. Learn more at www.carnivoredietdocumentary.com.Excitingly, we’re working on an upcoming documentary where we’ll feature carnivores from various walks of life, conquering diverse health challenges. Join us on this journey and learn more at www.carnivoredietdocumentary.com.Join us in uncovering the power of the carnivore diet. Prepare to be inspired, informed, and empowered to embrace optimal health and well-being.Welcome to “Carnivores Don’t Get Sunburn: Unveiling Real Stories of the Carnivore Diet.” Stay tuned for our upcoming documentary. Discover how this lifestyle can transform lives. Learn more at www.carnivoredietdocumentary.com The Laura Ingraham Show Laura Ingraham The most-watched woman in the history of cable news brings her no-holds-barred political and cultural commentary to podcasting with The Laura Ingraham Show. A bestselling author, breast cancer survivor, and mother of three internationally adopted children, Laura was the most listened-to woman in talk radio before launching her own podcast. A trailblazer across media platforms, she brings a unique perspective to this twice-weekly show, drawing on her experience as a white-collar criminal defense litigator and a Supreme Court law clerk.New episodes drop twice a week—delivering the clarity, courage, and common sense America needs. IT IS WHAT IT IS with SHALLZ - SHALLY ZOMORODI Shally Zomorodi What? "It is what it is" with ShallZ – Shally ZomorodiWhen? WeeklyHow long? 35 minutesEvery week, Mother of 4, wife, morning TV news anchor and ultimate hostess, Shally Zomorodi talks about life - its up's and downs and how to stay on track in her weekly podcast, ‘It is what it is.’ Known for her high energy, infectious smile and ability to see the cup as half full Shally talks about all things in life and how to work through its challenges. From parenting, marriage, friendships, current events to how to smile when it just seems impossible ‘It is what it is’ is the perfect podcast to help inspire you to dance through the rain.

Frequently Asked Questions

How long is this episode of Blood Cancer Talks?

This episode is 44 minutes long.

When was this Blood Cancer Talks episode published?

This episode was published on January 22, 2026.

What is this episode about?

BloodCancerTalks: ASH 2025 Lymphoma RoundupGuest: Dr. Carla Casulo, Associate Professor, Wilmot Cancer Centre, University of RochesterAbstracts DiscussedFollicular LymphomaEPCORE-FL1 (Falchi) - Epcoritamab plus lenalidomide-rituximab (R2) in...

Can I download this Blood Cancer Talks episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.